Tag archive for ‘Biotech/Medical/Science’
Syndicated Press Releases On Saturday, September 27th, 2014

SignaBlok Awarded NIH Grant to Test New Therapy for Rheumatoid Arthritis

SignaBlok, Inc. was awarded a new $223, 013 NIAMS/NIH grant to develop a novel approach for targeted therapy of rheumatoid arthritis. Online PR News – 27-September-2014 – The National Institute More...

Syndicated Press Releases On Wednesday, July 30th, 2014

SignaBlok Wins $1.34M NIH Phase II Grant to Advance New Nanotechnology for Atherosclerosis Imaging

SignaBlok, Inc. was awarded a new NIH SBIR Phase II grant totaling $1.34 million for continuing development of new nanotechnology-based atherosclerosis imaging Online PR News – 30-July-2014 – More...

Wordpress site Developed by Fixing WordPress Problems